SCHEMBL207964

SCHEMBL207964

Cc1cnc(C(=O)N2CCN(C(=O)CCC(=O)NC3CCC(Cc4cccc(Cl)c4)(N(C)C)CC3)CC2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
SIGMAR1 Q99720 4/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
ACKR3 P25106 1/20 0.38
EPHX2 P34913 1/20 0.38
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
MAPK1 P28482 1/20 0.36
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206115 0.91 NPC1 (0.38) ALDH1A1LMNAHTTMAPK1PRKAB2
SCHEMBL206152 0.87 POLB (0.37) ALDH1A1POLBLMNAHTTMAPK1
SCHEMBL206576 0.86 ALDH1A1 (0.44) ALDH1A1EPHX2LMNAHTTPRKAB2
SCHEMBL4081400 0.85 SIGMAR1 (0.46) ALDH1A1SIGMAR1MAPTTHRBHPGD
SCHEMBL207761 0.84 ALDH1A1 (0.51) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL205163 0.84 SIGMAR1 (0.44) ALDH1A1SIGMAR1THRBHPGDEPHX2
SCHEMBL205785 0.83 MEN1 (0.43) ALDH1A1MAPTEPHX2LMNAMEN1
SCHEMBL208174 0.83 SIGMAR1 (0.43) ALDH1A1SIGMAR1MAPTTHRBHPGD
SCHEMBL205991 0.82 USP2 (0.52) ALDH1A1POLBMAPTHPGDLMNA
SCHEMBL4081492 0.82 HTR1A (0.45) ALDH1A1SIGMAR1THRBHPGDEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885SIGMAR1 3262/4885POLB 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.